Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021
- Study Title
- A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021
- Teva Identifier
- DR-DSG-302
- ClinicalTrials.gov Identifier
- NCT00544882
- Study Status
- Completed
- Trial Condition(s)
- Healthy
- Interventions
- Drug: DR-1021 | Drug: Mircetteֲ® | Drug: Karivaֲ®
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female
- Age group
- Adult
- Age Range
- 18 Years to 35 Years
- Trial Duration
- 10/01/2007 - 03/01/2008
- Phase
- Phase 3
